Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?

doi:10.3748/wjg.v20.i46.17648

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6243)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

441

WORD

223

HTML

2769

Figures (1-6)

191

Tables (1-3)

159

Sum=3783

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1111

Download

1349

Sum=2460

Dec 14, 2014 (publication date) through Aug 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Dec 14, 2014; 20(46): 17648-17655
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17648

Full Size Figure Download Figure

Figure 5 No significant difference in overall survival between the gemcitabine plus radiotherapy group and the gemcitabine alone group.

Citation: Zhang X, Huang HJ, Feng D, Yang DJ, Wang CM, Cai QP. Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer? World J Gastroenterol 2014; 20(46): 17648-17655
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17648.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17648